LSA
SRPT icon

Leonteq Securities AG’s Sarepta Therapeutics SRPT Stock Holding History

Leonteq Securities AG’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
5,845
+2,282
+64% +$43.2K ﹤0.01% 679
2026
Q1 		$77.5K Buy
3,563
+37
+1% +$716 ﹤0.01% 783
2025
Q4 		$75.9K Sell
3,526
-7,859
-69% -$166K ﹤0.01% 869
2025
Q3 		$219K Buy
11,385
+4,953
+77% +$88.3K 0.01% 592
2025
Q2 		$110K Buy
6,432
+2,961
+85% +$126K ﹤0.01% 702
2025
Q1 		$220K Buy
3,471
+1,129
+48% +$119K 0.01% 521
2024
Q4 		$285K Buy
2,342
+2,107
+897% +$258K 0.02% 468
2024
Q3 		$29.3K Buy
235
+231
+5,775% +$31.9K ﹤0.01% 859
2024
Q2 		$632 Sell
4
-734
-99% -$94.3K ﹤0.01% 1145
2024
Q1 		$95.5K Buy
+738
New +$90.4K 0.01% 643
2023
Q3 		– Sell
-90
Closed -$10.3K – 1288
2023
Q2 		$10.3K Hold
90
– – ﹤0.01% 1036
2023
Q1 		$12.4K Buy
90
+89
+8,900% +$11.5K ﹤0.01% 989
2022
Q4 		$130 Sell
1
-11
-92% -$1.27K ﹤0.01% 1260
2022
Q3 		$1.33K Sell
12
-10
-45% -$1.01K ﹤0.01% 1203
2022
Q2 		$1.65K Buy
22
+21
+2,100% +$1.54K ﹤0.01% 1213
2022
Q1 		$78 Hold
1
– – ﹤0.01% 1222
2021
Q4 		$90 Buy
+1
New +$85 ﹤0.01% 1242
2021
Q3 		– Sell
-1,200
Closed -$93.3K – 1214
2021
Q2 		$93.3K Sell
1,200
-400
-25% -$30.3K 0.01% 725
2021
Q1 		$119K Buy
1,600
+1,050
+191% +$96.9K 0.01% 646
2020
Q4 		$93.8K Buy
+550
New +$81.5K 0.01% 692

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Leonteq Securities AG's SRPT Position: Q2 2026 in Review

Leonteq Securities AG increased its Sarepta Therapeutics (SRPT) stake by 64% in Q2 2026, buying an estimated $43.2K and bringing the position to 5,845 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Leonteq Securities AG first reported a position in SRPT in Q4 2020 and has held it in 20 quarters since. The position peaked at $285K in Q4 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Leonteq Securities AG held 5,845 shares of Sarepta Therapeutics worth $105K as of Q2 2026.
  • Leonteq Securities AG bought 2,282 Sarepta Therapeutics shares in Q2 2026, an estimated $43.2K.
  • Sarepta Therapeutics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #679 holding.
  • Leonteq Securities AG first reported a position in Sarepta Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • Leonteq Securities AG's Sarepta Therapeutics position peaked at $285K in Q4 2024.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.